6-Nitroindazole CAS 7597-18-4 Puritas >98.0% (GC) Factory

Description:

Chemical Name: 6-Nitroindazole

Synonyma: 6-nitro-1H-Indazole

CAS: 7597-18-4

Puritas: >98.0% (GC)

Aspectus: lux Yellow ut lux Brown pulveris

High Quality, Commercial Production

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 6-Nitroindazole (CAS: 7597-18-4) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. If you are interested in this product, please send detailed information includes CAS number, product name, quantity to us. Please contact: alvin@ruifuchem.com

Chemical Properties:

Nomen chemicum	6-Nitroindazole
Synonyma	6-Nitro-1H-Indazole;6-Nitro-1(2)H-Indazole;6-Nitro-Indazole
CAS Number	7597-18-4
CATTUS Number	RF2675
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C7H5N3O2
M. Pondus	180.0 ad 184.0163.14
Density	1.525
Solubilitas in Hot Methanol	Ipsum sedat Turbidity
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Lumen Yellow ut lux Brown Pulvis
Puritas / Analysis Methodus	>98.0% (GC)
Liquescens punctum	180.0 ad 184.0℃
Damnum in Siccatio	<1.00%
Totalis immunditias	<2.00%
Infrared Imaginis	Conformat ut Structure
Proton NMR Spectrum	Conformat ut Structure
Test Standard	Enterprise Standard
Consuetudinem	Pharmaceutical intermedia

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

Satis capacitas: sufficientes facilities et technici

Professional Service: One stop acquireing service

Altera Package: Custom sarcina ac titulus praesto

Ieiunium Delivery: Si intra stirpem, tres dies partus praestatur

Supple firmum: Esse rationabile stirpe

Technical Support: Technology solution praesto

Custom Synthesis Service: Range from P. to kilos

High Quality: Constitutus ratio completa qualitas certitudinis

FAQ:

Quam mercari?Please contact: sales@ruifuchem.com or alvin@ruifuchem.com

15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.

Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Russiam, Coream, Iaponicam, Australiam etc.

Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.

Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.

Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.

Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.

MOQ?Nec MOQ.Parvus ordo placet.

Tempus adferendi? Si intus prosapia, tres dies partus praestatur.

Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.

Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.

Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.

Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.

Applicatio:

6-Nitroindazole (CAS: 7597-18-4) adhibetur ut medium pharmaceuticum, Axitinib/AG013736 medium.Axitinib (AG-013736) multiplex inhibitor inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ et c-ornamentum cum IC50 inter 0.1 nM, 0.2 nM, 0.1-0.3 nM, 1.6 nM et 1.7 nM, respective.Axitinib est inhibitor tyrosine kinase.Axitinib in cancer justo adhibetur.Mense Ianuario 2012, US FDA axitinib approbavit (etiam AG-013736) ad tractationem carcinomatis renalis provectae (RCC) aegris qui priori therapio non responderunt.Axitinib est sartagine VEGF inhibitor et functiones ligans ad dominium intracellularem tyrosinum kinasum catalyticum VEGF ducens obsidionem significandi per hoc angiogenicum iter.